Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia - Wikidata - wikimedia - TriplyDB

Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia

Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia

http://www.wikidata.org/entity/Q34313640

about

Breaking the Spell: Combating Multidrug Resistant 'Superbugs'Vaccination against respiratory Pseudomonas aeruginosa infection Vaccines for Pseudomonas aeruginosa: a long and winding road Vaccine approaches for multidrug resistant Gram negative infections The B lymphocyte differentiation factor (BAFF) is expressed in the airways of children with CF and in lungs of mice infected with Pseudomonas aeruginosa Microbiota in T-cell homeostasis and inflammatory diseases Transcriptomic Analysis on Responses of Murine Lungs to Pasteurella multocida Infection.Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models.Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye.SuhB is a regulator of multiple virulence genes and essential for pathogenesis of Pseudomonas aeruginosa.Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia.Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F Antigen-Specific Mammary Inflammation Depends on the Production of IL-17A and IFN-γ by Bovine CD4+ T Lymphocytes.Innate Immune Signaling Activated by MDR Bacteria in the Airway Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of Pseudomonas aeruginosa.Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology.Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.Pseudomonas aeruginosa Enolase Influences Bacterial Tolerance to Oxidative Stresses and Virulence.Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients.Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin.Th17 cell based vaccines in mucosal immunity.Update in pulmonary infections 2012.Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations.A tale of two cytokines: IL-17 and IL-22 in asthma and infection.Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.New perspectives in the management of Pseudomonas aeruginosa infections.Harnessing the Therapeutic Potential of Th17 Cells.Airway Microbiota and the Implications of Dysbiosis in Asthma.Immunization with Bivalent Flagellin Protects Mice against Fatal Pseudomonas aeruginosa Pneumonia.40 years on: have we finally got a vaccine for Pseudomonas aeruginosa?Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.Binding mode analysis of a major T3SS translocator protein PopB with its chaperone PcrH from Pseudomonas aeruginosa.Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae

P2860

Q26765868-3BD04F5A-170B-401F-9204-C1AA667DCEE2 Q26824014-33F987F4-F370-4FDE-8C5F-8F3FF4C10E05 Q26852817-545571AD-35B0-488C-A316-B80CB18DDF58 Q27007042-5DF57E48-223F-49FF-ACA9-A3CC621D31A7 Q33644527-DE2B5380-40B1-4B69-832E-6721D920CE0A Q33754038-56DB9481-8A25-41A7-93B2-4BBC6C9B9B76 Q33813222-AC7AAF31-DC28-4B54-90E8-1E7CE6ED0D3A Q33822579-25507F92-C978-46AE-9EA4-E7CED5E0830D Q34059043-289007DD-6F38-4D0C-9082-F91716B41006 Q35028331-07B862C0-13EA-4584-B2B2-22B7730D16E8 Q35717842-DAE8644E-0A25-46DA-9966-347B71B69D30 Q35766685-C89B4D74-0050-44D3-BC17-5552D10C1D51 Q35777149-9C4FC74E-5413-4765-A6E1-2E4ED3384174 Q36422470-81C5C3B6-AE3A-4F01-BF7D-A2085FE500AC Q36448826-BE333727-D214-48C6-AA33-022B5F9DDD82 Q36888565-A7D83B63-AC51-49DE-B1F3-1773115AF331 Q36946903-36528A2E-6EDF-4092-BAD7-840F64B03F24 Q37265849-A46148E7-599A-4E13-A248-B8C8F52C48FB Q37502444-95645741-4089-4869-A6B7-2E0E5BCDB7B2 Q37503911-61C5EA27-8C57-492E-971D-7CA4DBBB3B5C Q37620529-1FB574D6-D312-4F8A-AD34-9EFDC8C256A8 Q37624611-CD4A8D5E-4DA2-4651-86FA-53003AB26B00 Q37641941-3BCC7ACB-D555-4A3C-8FE9-0A6257A6F607 Q37697412-7CBF54AA-E8E4-415B-BAE5-169CCE2A38B3 Q37713295-9E068F74-BB2C-4209-89C2-E63C757EA2A4 Q38106558-E089517B-47E4-46E7-9EDE-D6E9339FCA6B Q38106995-9EEB7D19-280E-496F-AC0E-77E06DD8F172 Q38168915-A36BA6B5-CFCD-4AAD-8399-42A5F3D043C3 Q38170180-57E80B7F-D788-434E-A275-E8D35E5F6B55 Q38210319-A1132CA7-262D-46C3-AEFC-2A8D1B77AD3C Q38243221-A4561F21-3FD6-4B99-A31B-C317DF8D46AB Q38535119-A6B07A84-6524-4C1F-A698-088F1FAF1A13 Q38890722-CC295E53-0E5F-42E9-8502-125EA55A189C Q45174642-4D641402-DF53-45A0-B46C-94B6F0A3A0A8 Q51532849-33392608-E0FB-4C28-AF22-00EE3D66B623 Q52448914-C947AEA4-E92F-4EBE-A891-6BAD6086E6B4 Q53028079-EA0135C9-A2B9-4C34-9826-F102865D0D09 Q54221826-AE73188E-2F65-4C10-9882-C04289268492 Q55048565-399CCB6E-D4C1-4B74-8712-9AEEE51A598F Q58698200-D7571FCE-9600-4E97-821C-A7D9830C2ECB

P2860

Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia

http://www.wikidata.org/entity/Q34313640

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@ast

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@en

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@nl

type

label

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@ast

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@en

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@nl

prefLabel

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@ast

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@en

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@nl

P1433

Q34313640-8398807F-E379-4F1F-B017-A1722F787E59

P1476

Q34313640-2AAF44D1-DA16-49CC-83B4-2F13CC689C68

P2093

Q34313640-11AA581F-88D6-43DD-B54D-A5C24F69C254

Q34313640-33E387D7-B894-4AD2-AD8D-0AEBE37A0977

Q34313640-4DCA8F99-B1FA-465E-B687-D39CA791BF49

Q34313640-510B4BCD-0E74-4E5A-9BBE-C53F5DAF0FCD

Q34313640-739E8A9C-0E7C-4B79-8670-4F369DEDB5C9

Q34313640-91ACF841-E7E7-4A50-894A-906C17DED3FD

Q34313640-9BCF7D21-5AAE-4D3D-85DF-E169C4431FAD

Q34313640-ADDEF655-F267-4719-ADE3-D59A53FB628E

P2860

Q34313640-023433FB-A366-473F-BD51-BB53BD5D607E

Q34313640-090FBD0C-5426-4FA9-A7B5-A301C9AFBA0B

Q34313640-0AD62F17-2934-4747-952D-0741365265A8

Q34313640-0CC2B57C-A0F6-4B32-8656-AC87D947C20A

Q34313640-0FAFF84F-5682-4AB4-8025-19F0C610050D

Q34313640-21D32C1B-2F0C-4048-BB87-4B589727B8CB

Q34313640-21E8A17A-88FB-4EC4-81F8-1FADA01C5BA3

Q34313640-26953116-5B75-4A7A-A8D5-BE7D81D4292B

Q34313640-2B0BFC83-EE91-4DA1-B5A2-3CFBE89B16A2

Q34313640-31EEBC1A-9218-4F30-ADD2-9A1F2650C6A7

P304

Q34313640-F2AB6665-3E8C-4D35-83CF-BF9A4EE859F8

P31

Q34313640-DB3688BC-39AD-499B-91F9-CA18EC00F4BB

P356

Q34313640-75904B03-9A8F-451B-92AA-5ADD49E46E4B

P407

Q34313640-CCF1ED28-CE65-49E8-85C4-02E1CB08F3AA

P433

Q34313640-256A7B71-0E96-47D3-8DD8-3DE5BFAE25AF

P478

Q34313640-7B9B2199-9FEE-4295-ADC5-373578FAC8D4

P577

Q34313640-6B1C5EB6-2CEC-48AD-A054-139E9BDE2F59

P698

Q34313640-1621B436-655A-4C1F-BEEF-97F98D591908

P921

Q34313640-6FE9D41D-E760-417B-8999-37AD22F87036

Q34313640-C67167C6-1637-4E6A-9BF9-E604F14C3D8C

P932

Q34313640-72EA838F-960C-48DC-9694-28EFE9FD7B3A

P356

RCCM.201202-0182OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Th17-stimulating protein vacci ...... eudomonas aeruginosa pneumonia

@en

P2093

Biyan Duan

http://www.w3.org/2001/XMLSchema#string

David C Traficante

http://www.w3.org/2001/XMLSchema#string

Gregory P Priebe

http://www.w3.org/2001/XMLSchema#string

Haeyeon Hong

http://www.w3.org/2001/XMLSchema#string

Jin Huang

http://www.w3.org/2001/XMLSchema#string

Martina Risech

http://www.w3.org/2001/XMLSchema#string

Stephen Lory

http://www.w3.org/2001/XMLSchema#string

Weihui Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis

PcrH of Pseudomonas aeruginosa is essential for secretion and assembly of the type III translocon

PtrB of Pseudomonas aeruginosa suppresses the type III secretion system under the stress of DNA damage.

IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.

Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.

Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine

Pseudomonas aeruginosa population structure revisited.

Interleukin-17A mediates acquired immunity to pneumococcal colonization

Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.

Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread

P304

420-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201202-0182OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22723292

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

3443805

http://www.w3.org/2001/XMLSchema#string